Fixed dose combination

Results: 323



#Item
91Gilead Sciences / Pharmacology / Carbamates / Fixed dose combination / Organofluorides / Lopinavir/ritonavir / Lopinavir / Antiretroviral drug / Darunavir / Chemistry / Protease inhibitors / Organic chemistry

ABT-378 M02-418 Clinical Study Report R&D[removed]

Add to Reading List

Source URL: www.abbvie.com

Language: English - Date: 2014-12-18 16:28:01
92Carbamates / Organofluorides / Fixed dose combination / Lopinavir/ritonavir / Bristol-Myers Squibb / Antiretroviral drug / Lopinavir / Reverse-transcriptase inhibitor / Efavirenz / Chemistry / Organic chemistry / Protease inhibitors

Lopinavir/ritonavir (ABT-378) M03-613 Clinical Study Report R&D[removed]

Add to Reading List

Source URL: www.abbvie.com

Language: English - Date: 2014-12-18 17:16:43
93Gilead Sciences / Fixed dose combination / Organofluorides / Cyclopropanes / Antiretroviral drug / Efavirenz / Reverse-transcriptase inhibitor / Emtricitabine / Abacavir / Chemistry / Organic chemistry / Non-nucleoside reverse transcriptase inhibitors

How to use this document:

Add to Reading List

Source URL: www.vdh.state.va.us

Language: English - Date: 2014-12-11 13:07:15
94Pharmacology / Carbamates / Fixed dose combination / Organofluorides / Antiretroviral drug / Lopinavir/ritonavir / Reverse-transcriptase inhibitor / Zidovudine / Lamivudine / Chemistry / Protease inhibitors / Organic chemistry

Lopinavir/ritonavir M01-384 Abbreviated Clinical Study Report R&D[removed]

Add to Reading List

Source URL: www.abbvie.com

Language: English - Date: 2014-12-18 16:27:55
95HIV/AIDS / Medicine / Carbamates / Fixed dose combination / Organofluorides / Lopinavir/ritonavir / Lopinavir / Antiretroviral drug / Lamivudine / Chemistry / Protease inhibitors / Organic chemistry

Kaletra® FRAN[removed]Clinical Study Report R&D[removed]2.0

Add to Reading List

Source URL: www.abbvie.com

Language: English - Date: 2014-12-18 16:27:13
96Pharmacology / Protease inhibitors / Amides / Organofluorides / Antiretroviral drug / Integrase inhibitors / Lopinavir/ritonavir / Tenofovir/emtricitabine / Lopinavir / Chemistry / Organic chemistry / Fixed dose combination

Lopinavir/ritonavir M10-336 Clinical Study Report 2.0 Synopsis

Add to Reading List

Source URL: www.abbvie.com

Language: English - Date: 2014-12-18 17:16:43
97Gilead Sciences / HIV/AIDS / Organofluorides / Fixed dose combination / Integrase inhibitors / Antiretroviral drug / Raltegravir / Tenofovir/emtricitabine / Emtricitabine / Chemistry / Medicine / Organic chemistry

Expert Advisory Group on AIDS Providing expert scientific advice on HIV Change to recommended regimen for post-exposure prophylaxis (PEP) EAGA was asked to review its recommended regimen for occupational postexposure pro

Add to Reading List

Source URL: www.gov.uk

Language: English - Date: 2014-09-08 10:26:15
98HIV/AIDS / Medicine / Organofluorides / Fixed dose combination / Bristol-Myers Squibb / Antiretroviral drug / Emtricitabine/tenofovir/efavirenz / Tenofovir/emtricitabine / Tenofovir / Chemistry / Gilead Sciences / Organic chemistry

Management of HIV Infection in the Difficult to Treat or Reach Population According to 2011 national estimates, there were 71,300 Canadians living with HIV, an increase of 7,300 people since[removed]The Canadian epidemic

Add to Reading List

Source URL: novaclinical.com

Language: English - Date: 2014-11-05 12:34:13
99Pharmacology / Health / Fixed dose combination / Microbicides / Purines / Tenofovir / HIV / AIDS / Emtricitabine / Gilead Sciences / Medicine / HIV/AIDS

Licensing and Collaboration: Ensuring Sustainable and Affordable Access to HIV Medicines At Janssen, we believe that our commitment and responsibility is to the people in need of our medicines, today and in the future. I

Add to Reading List

Source URL: www.janssenrnd.com

Language: English - Date: 2012-07-18 12:14:00
100Chemistry / Cipla / Tenofovir / Emtricitabine / Antiretroviral drug / Fixed-dose combination / Emcure Pharmaceuticals / Zidovudine / AIDS / Gilead Sciences / Medicine / Health

The Medicines Patent Pool Adds New Sub-Licensing Agreements to Improve Access to Novel ARVs in Developing Countries MPP signs sub-licences with six generic manufacturers for the development of Phase III drug Tenofovir Al

Add to Reading List

Source URL: unitaid.org

Language: English - Date: 2014-09-25 08:57:27
UPDATE